Yang So Dam, Shin Seonghye, Lee Jiyoon
Life Sciences, LG Chem, Ltd., Seoul, Republic of Korea.
Plast Reconstr Surg Glob Open. 2020 Jul 23;8(7):e2975. doi: 10.1097/GOX.0000000000002975. eCollection 2020 Jul.
YVOIRE Classic s (YC) and Restylane (RES) have similar rheological properties, which suit mid-dermis injection, while the rheological properties of YVOIRE Volume s (YV) are comparable to those of Perlane (PER), which suit deep dermis injection to treat deep wrinkles. Two similarly designed studies aimed to evaluate the performance and safety of YC and YV injected into the nasolabial folds (NLFs).
These were split-face designed, evaluator-blind, noninferiority studies. Fifty-eight subjects with moderate-to-severe NLFs were enrolled in the first study and treated with YC and RES, and 57 subjects were enrolled in the second study and treated with YV and PER. The Wrinkle Severity Rating Scale ranged from 1 (no visible fold) to 5 (extremely deep and long folds), and subject satisfaction was evaluated.
The least squares mean Wrinkle Severity Rating Scale scores (standard error) at week 26 were 2.56 (0.09) for both YC- and RES-treated NLFs and 2.89 (0.08) and 2.91 (0.08) for YV- and PER-treated NLFs, respectively. The difference between the groups was 0 and 0.02, and the lower limit of its 95% confidence interval was -0.0725 and -0.0125, which was greater than the predefined margin (-0.29), proving the noninferiority of YC and YV to RES and PER, respectively. The safety profiles and subject satisfaction of YC and YV were similar to those of RES and PER, respectively.
YC is comparable to RES and YV is comparable to PER in terms of performance and safety profiles, with NLF-correcting effects lasting for up to 26 weeks.
伊婉经典款(YC)和瑞蓝(RES)具有相似的流变学特性,适合真皮中层注射,而伊婉致美款(YV)的流变学特性与百洛娜(PER)相当,适合真皮深层注射以治疗深层皱纹。两项设计相似的研究旨在评估将YC和YV注射到鼻唇沟(NLF)中的性能和安全性。
这些是半脸设计、评估者盲法、非劣效性研究。第一项研究招募了58名中重度鼻唇沟患者,分别用YC和RES进行治疗,第二项研究招募了57名患者,用YV和PER进行治疗。皱纹严重程度评分量表范围从1(无可见褶皱)到5(极深且长的褶皱),并评估了患者满意度。
在第26周时,接受YC和RES治疗的鼻唇沟的最小二乘均值皱纹严重程度评分量表得分(标准误差)均为2.56(0.09),接受YV和PER治疗的鼻唇沟得分分别为2.89(0.08)和2.91(0.08)。两组之间的差异分别为0和0.02,其95%置信区间的下限分别为-0.0725和-0.0125,大于预先设定的界值(-0.29),分别证明了YC和YV相对于RES和PER的非劣效性。YC和YV的安全性和患者满意度分别与RES和PER相似。
在性能和安全性方面,YC与RES相当,YV与PER相当,鼻唇沟矫正效果可持续长达26周。